Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials

Summary Background For patients with end-stage renal disease who are not candidates for fistula, dialysis access grafts are the best option for chronic haemodialysis. However, polytetrafluoroethylene arteriovenous grafts are prone to thrombosis, infection, and intimal hyperplasia at the venous anast...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 2016-05, Vol.387 (10032), p.2026-2034
Hauptverfasser:	Lawson, Jeffrey H, MD PhD, Glickman, Marc H, MD, Ilzecki, Marek, MD PhD, Jakimowicz, Tomasz, MD PhD, Jaroszynski, Andrzej, MD PhD, Peden, Eric K, MD, Pilgrim, Alison J, MD PhD, Prichard, Heather L, PhD, Guziewicz, Malgorzata, MD PhD, Przywara, Stanisław, MD PhD, Szmidt, Jacek, MD PhD, Turek, Jakub, MD, Witkiewicz, Wojciech, MD PhD, Zapotoczny, Norbert, MD, Zubilewicz, Tomasz, MD PhD, Niklason, Laura E, Dr
Format:	Artikel
Sprache:	eng
Schlagworte:	Bioengineering Blood Vessel Prosthesis Cells, Cultured Clinical trials Dialysis Female Graft Survival Hemodialysis Humans Immune response Internal Medicine Kidney diseases Kidney Failure, Chronic - therapy Male Mechanical failure Middle Aged Muscle, Smooth, Vascular - cytology Polytetrafluoroethylene - therapeutic use Prosthesis Design Renal Dialysis - instrumentation Skin & tissue grafts Thromboembolism Thrombosis Vascular Access Devices Veins & arteries
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!